novolog mix 70/30

Generic: insulin aspart

Labeler: novo nordisk
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name novolog mix 70/30
Generic Name insulin aspart
Labeler novo nordisk
Dosage Form INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients

insulin aspart 100 [iU]/mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-3696
Product ID 0169-3696_ecfd53fb-5887-48df-bc66-c32f8ff0cf67
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA021172
Listing Expiration 2026-12-31
Marketing Start 2002-09-11

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01693696
Hyphenated Format 0169-3696

Supplemental Identifiers

RxCUI
351297 847191 977840 977842
UNII
D933668QVX
NUI
M0011417 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name novolog mix 70/30 (source: ndc)
Generic Name insulin aspart (source: ndc)
Application Number BLA021172 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (1)

0169-3696-19 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) / 3 mL in 1 SYRINGE, PLASTIC

Ingredients (1)

insulin aspart (100 [iU]/mL)

Linked Drug Pages (1)

NovoLog Mix 70/30 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "ecfd53fb-5887-48df-bc66-c32f8ff0cf67", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["D933668QVX"], "rxcui": ["351297", "847191", "977840", "977842"], "spl_set_id": ["1861fcee-7673-4afe-a206-08fa05c0add2"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-3696-19", "marketing_start_date": "20020911"}], "brand_name": "NovoLog Mix 70/30", "product_id": "0169-3696_ecfd53fb-5887-48df-bc66-c32f8ff0cf67", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0169-3696", "generic_name": "insulin aspart", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NovoLog Mix 70/30", "active_ingredients": [{"name": "INSULIN ASPART", "strength": "100 [iU]/mL"}], "application_number": "BLA021172", "marketing_category": "BLA", "marketing_start_date": "20020911", "listing_expiration_date": "20261231"}